secwatch.observer — SEC 8-K summary
======================================

Issuer:     Strata Critical Medical, Inc. (SRTA)
CIK:        0001779128
Form:       8-K
Filed at:   2024-03-20T23:59:59+00:00
Accession:  0001779128-24-000040
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Blade Air Mobility announces up to $20M share repurchase program; expects FY2024 adj. EBITDA profit
--------------------------------------------------------------------------------

- Board authorized repurchase of up to $20M of Class A common stock; program effective through March 31, 2025.
- Repurchases to be funded from cash on hand and cash from operations; program may be suspended or discontinued at any time.
- Company expects full-year 2024 profitability on an adjusted EBITDA basis, with debt-free balance sheet and significant cash.
- Volume and timing of repurchases subject to market conditions, acquisition opportunities, and capital allocation strategy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1779128/000177912824000040/0001779128-24-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1779128/000177912824000040/blde-20240320.htm
  HTML page:      https://secwatch.observer/filing/0001779128-24-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer